Cerebellar Blood Flow and Gene Expression in Crossed Cerebellar Diaschisis after Transient Middle Cerebral Artery Occlusion in Rats.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
10 Jun 2020
Historique:
received: 10 04 2020
revised: 05 06 2020
accepted: 08 06 2020
entrez: 14 6 2020
pubmed: 14 6 2020
medline: 26 3 2021
Statut: epublish

Résumé

Crossed cerebellar diaschisis (CCD) is a state of hypoperfusion and hypometabolism in the contralesional cerebellar hemisphere caused by a supratentorial lesion, but its pathophysiology is not fully understood. We evaluated chronological changes in cerebellar blood flow (CbBF) and gene expressions in the cerebellum using a rat model of transient middle cerebral artery occlusion (MCAO). CbBF was analyzed at two and seven days after MCAO using single photon emission computed tomography (SPECT). DNA microarray analysis and western blotting of the cerebellar cortex were performed and apoptotic cells in the cerebellar cortex were stained. CbBF in the contralesional hemisphere was significantly decreased and this lateral imbalance recovered over one week. Gene set enrichment analysis revealed that a gene set for "oxidative phosphorylation" was significantly upregulated while fourteen other gene sets including "apoptosis", "hypoxia" and "reactive oxygen species" showed a tendency toward upregulation in the contralesional cerebellum. MCAO upregulated the expressions of nuclear factor erythroid 2-related factor 2 (Nrf2) and heme oxygenase-1 (HO-1) in the contralesional cerebellar cortex. The number of apoptotic cells increased in the molecular layer of the contralesional cerebellum. Focal cerebral ischemia in our rat MCAO model caused CCD along with enhanced expression of genes related to oxidative stress and apoptosis.

Identifiants

pubmed: 32531947
pii: ijms21114137
doi: 10.3390/ijms21114137
pmc: PMC7312675
pii:
doi:

Substances chimiques

NF-E2-Related Factor 2 0
Nfe2l2 protein, rat 0
Heme Oxygenase (Decyclizing) EC 1.14.14.18
Hmox1 protein, rat EC 1.14.14.18

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Mol Psychiatry. 2020 Jun;25(6):1202-1214
pubmed: 30108315
Neuromolecular Med. 2020 Jun;22(2):278-292
pubmed: 31900786
PLoS One. 2014 Feb 05;9(2):e88044
pubmed: 24505372
Front Aging Neurosci. 2017 Feb 17;9:10
pubmed: 28261086
J Nucl Med. 2011 Dec;52(12):1987-92
pubmed: 22049462
Arch Neurol. 2004 Feb;61(2):283-8
pubmed: 14967781
Eur J Nucl Med Mol Imaging. 2007 Feb;34(2):151-61
pubmed: 17143647
J Nucl Med. 1998 Dec;39(12):2044-7
pubmed: 9867139
Neuroimage. 2001 Sep;14(3):723-35
pubmed: 11506544
J Cereb Blood Flow Metab. 1999 May;19(5):467-82
pubmed: 10326714
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7699-704
pubmed: 12032346
Turk Neurosurg. 2011;21(4):567-74
pubmed: 22194118
AJNR Am J Neuroradiol. 2005 Oct;26(9):2224-8
pubmed: 16219826
Free Radic Biol Med. 2015 Nov;88(Pt B):93-100
pubmed: 26117331
Arch Phys Med Rehabil. 2019 Jul;100(7):1308-1316
pubmed: 30876843
Cell Physiol Biochem. 2018;46(1):57-68
pubmed: 29587284
Brain Res. 2013 Nov 6;1537:350-5
pubmed: 24076448
J Cereb Blood Flow Metab. 2007 Oct;27(10):1724-32
pubmed: 17311077
J Cereb Blood Flow Metab. 2005 Dec;25(12):1685-91
pubmed: 15931159
Front Integr Neurosci. 2012 May 21;6:20
pubmed: 22661933
Cell Physiol Biochem. 2017;41(4):1403-1412
pubmed: 28315868
Clin Nucl Med. 2013 Dec;38(12):957-61
pubmed: 24152651
Neuropharmacology. 2014 Apr;79:298-306
pubmed: 24262633
Int J Stroke. 2016 Jan;11(1):117-26
pubmed: 26763027
Sci Rep. 2016 Oct 13;6:35323
pubmed: 27734935
Stroke. 2001 Nov;32(11):2682-8
pubmed: 11692034
Front Pharmacol. 2019 Mar 05;10:153
pubmed: 30890934
Neurol Res. 2010 Oct;32(8):828-34
pubmed: 20426901
Brain. 2014 Sep;137(Pt 9):2408-22
pubmed: 24871646
Stroke. 1996 Sep;27(9):1616-22; discussion 1623
pubmed: 8784138
Ann Nucl Med. 2005 Jun;19(4):321-4
pubmed: 16097643
Trans Am Neurol Assoc. 1981;105:459-61
pubmed: 19645126
Stroke. 2004 Feb;35(2):472-6
pubmed: 14739422

Auteurs

Naoya Kidani (N)

Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Tomohito Hishikawa (T)

Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Masafumi Hiramatsu (M)

Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Shingo Nishihiro (S)

Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Kyohei Kin (K)

Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Yu Takahashi (Y)

Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Satoshi Murai (S)

Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Kenji Sugiu (K)

Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Takao Yasuhara (T)

Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Ikuko Miyazaki (I)

Department of Medical Neurobiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Masato Asanuma (M)

Department of Medical Neurobiology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Isao Date (I)

Department of Neurological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH